Literature DB >> 7979691

Successful use of deep hypothermic circulatory arrest in pregnancy.

E Buffolo1, J H Palma, W J Gomes, H Vega, D Born, A F Moron, A C Carvalho.   

Abstract

A woman pregnant for 21 weeks underwent an emergency operation because of an aortic arch aneurysm that had ruptured into her left lung. Cardiopulmonary bypass and deep hypothermia were used and she needed 37 minutes of circulatory arrest at a core temperature of 19 degrees C. Both the mother and fetus survived, and a normal baby was delivered by cesarean section at the 39th week of gestation.

Entities:  

Mesh:

Year:  1994        PMID: 7979691     DOI: 10.1016/0003-4975(94)91952-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Cardiac surgery during pregnancy.

Authors:  Anish Patel; Sanjay Asopa; Augustine T M Tang; Sunil K Ohri
Journal:  Tex Heart Inst J       Date:  2008

2.  Surgical treatment for acute type A aortic dissection during pregnancy (16 weeks) with Loeys-Dietz syndrome.

Authors:  Hideyuki Kunishige; Yoshimitsu Ishibashi; Masakazu Kawasaki; Tomoji Yamakawa; Kiyotaka Morimoto; Nozomu Inoue
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-05-25

3.  Successful surgical treatment for acute aortic dissection in pregnancy with Marfan's syndrome.

Authors:  Masayuki Sakaguchi; Hiroto Kitahara; Takayuki Watanabe; Tetsuya Kono; Daisuke Fukui; Jun Amano
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-04

4.  Indications for Cardiopulmonary Bypass During Pregnancy and Impact on Fetal Outcomes.

Authors:  S-M Yuan
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-01       Impact factor: 2.915

5.  Successful repair of acute type A aortic dissection during pregnancy at 16th gestational week with maternal and fetal survival: A case report and review of the literature.

Authors:  Su-Wei Chen; Yong-Liang Zhong; Yi-Peng Ge; Zhi-Yu Qiao; Cheng-Nan Li; Jun-Ming Zhu; Li-Zhong Sun
Journal:  World J Clin Cases       Date:  2019-09-26       Impact factor: 1.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.